Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEDoxy Tanzania
ISRCTN65756724Phase 2Completed
- Sponsor
- MRC National Institute for Medical Research
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of doxycycline in filariasis (3 arms), sponsored by MRC National Institute for Medical Research. Primary endpoint: Primary: lack of progression of lymphedema at 24 months. Started Jul 2018; status: completed.
02
Drugs
doxycycline
03
Conditions
filariasis
Beyond the preview
Go deeper on ISRCTN65756724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN65756724.